Evidence map›Paper›PMID 39215130›Full record

ArticleScientific reports2024

Biodistribution of PET radiotracers in tumor-bearing TRAMP mice administered by retroorbital or jugular vein injections.

Catherine C Applegate, Michael B Nelappana, Yuxiao Cui, Goodluck Okoro, Elaine A Nielsen, Nicolas P Dovalovsky, Andrew M Smith, Iwona T Dobrucki, Lawrence W Dobrucki

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Preclinical evaluation of FAP-targeted PET imaging to investigate CAF responses to radiotherapy.Cancer imaging : the official publication of the International Cancer Imaging Society · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Catherine C ApplegateDepartment of Bioengineering, University of Illinois at Urbana-Champaign, 405 N. Mathews Ave, MC-251, Urbana, IL, 61801, USA. cca2@illinois.edu.
Michael B NelappanaDepartment of Bioengineering, University of Illinois at Urbana-Champaign, 405 N. Mathews Ave, MC-251, Urbana, IL, 61801, USA.
Yuxiao CuiDepartment of Bioengineering, University of Illinois at Urbana-Champaign, 405 N. Mathews Ave, MC-251, Urbana, IL, 61801, USA.
Goodluck OkoroDepartment of Bioengineering, University of Illinois at Urbana-Champaign, 405 N. Mathews Ave, MC-251, Urbana, IL, 61801, USA.
Elaine A NielsenDepartment of Bioengineering, University of Illinois at Urbana-Champaign, 405 N. Mathews Ave, MC-251, Urbana, IL, 61801, USA.
Nicolas P DovalovskyDepartment of Bioengineering, University of Illinois at Urbana-Champaign, 405 N. Mathews Ave, MC-251, Urbana, IL, 61801, USA.
Andrew M SmithDepartment of Bioengineering, University of Illinois at Urbana-Champaign, 405 N. Mathews Ave, MC-251, Urbana, IL, 61801, USA.
Iwona T DobruckiDepartment of Bioengineering, University of Illinois at Urbana-Champaign, 405 N. Mathews Ave, MC-251, Urbana, IL, 61801, USA.
Lawrence W DobruckiDepartment of Bioengineering, University of Illinois at Urbana-Champaign, 405 N. Mathews Ave, MC-251, Urbana, IL, 61801, USA.

Funding

Notch signaling in diabetic woundsR01DK127531 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GALLAGHER, KATHERINE ANN · 2021 to 2024
$2.5M
Nanomedicine-Based Targeting of Inflammatory Macrophages in Diabetic Wound RepairR01DK131782 · NIDDK · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI Katherine Ann Gallagher, Andrew Michael Smith · 2022 to 2026
$2.4M
Targeted Drug Delivery to Adipose Tissue Macrophages in ObesityR01DK112251 · NIDDK · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI SMITH, ANDREW MICHAEL, SWANSON, KELLY S · 2016 to 2020
$2.1M
Macrophage-Targeted Drug Delivery Depot for Obesity and Comorbid Type 2 DiabetesR01DK139924 · NIDDK · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI Andrew Michael Smith · 2024 to 2026
$1.8M
Epigenetic Regulation of Prostaglandin E2 (PGE2) Synthesis Alters Macrophage Function to Promote Inflammation and Impair Diabetic Wound HealingR01DK124290 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GALLAGHER, KATHERINE ANN, MOORE, BETHANY B. · 2020 to 2023
$1.8M
Translational Combinations of Nanocarriers and Blockers for Metastatic Breast CancerR01CA288207 · NCI · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI ERIK Russell NELSON, Andrew Michael Smith · 2024 to 2026
$1.7M
NCI NIH HHS R01 CA288207NIDDK NIH HHS R01 DK112251NIDDK NIH HHS R01 DK124290NIDDK NIH HHS R01 DK127531NIDDK NIH HHS R01 DK131782NIDDK NIH HHS R01 DK139924NIH HHS R01DK112251
6 · The paper itself

Abstract

Nuclear medicine is an important tool for use in molecular imaging of important biological processes. Methods for intravenous delivery of radiotracers remains a challenge, with tail vein injections demonstrated to be technically difficult and lacking in reproducibility. Other intravenous methods include jugular vein (JV) injection, which requires a more invasive and precise microsurgical technique. Although the retroorbital (RO) sinus drains directly into the JV, and RO injections are minimally invasive and simpler to perform, they remain underutilized, perhaps due to a lack of studies demonstrating their performance. This study provides a comprehensive comparison of dynamic tissue biodistribution of three categories of commonly utilized radiopharmaceuticals between JV and RO injection methods in prostate tumor-bearing mice using PET-CT imaging. Results show that JV and RO injections have equivalent dynamic tissue biodistributions across the three categories of radiopharmaceuticals used: (1) small molecule measuring tumor metabolism (

Indexed as

Jugular VeinsProstatic NeoplasmsRadiopharmaceuticalsAnimalsCell Line, TumorInjections, IntravenousMaleMicePositron-Emission TomographyPositron Emission Tomography Computed TomographyTissue DistributionRadiopharmaceuticalsBiodistributionCRGDDextranJugularNanoparticlePETRetroorbital

Identifiers

PMID39215130
PMCPMC11364845

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.